Dr Clemence Girardet
Dr Clemence Girardet, a postdoctoral fellow in Dr Andrew Butler’s laboratory, was awarded a scholarship from the Keystone Symposia Future of Science Fund and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) .
Katie Stockstill, graduate student in Dr. Salvemini's laboratory, was awarded the American Pain Society Young Investigator Travel Award  to attend the the Annual Scientific Meeting of the American Pain Society, April 30- May 3, 2014 in Tampa, FL. Katie will be presenting her poster entitled "Bortezomib-induced neuropathic pain is blocked and reversed by blocking the the S1P/S1PR1 axis" on Thursday, May 1, 2014 as a part of this Annual Scientific Meeting.
Contact Us
Department of Pharmacological and Physiology
Room M 362 || 1402 South Grand Blvd
St. Louis, Missouri 63104
Phone: 314-977-6400
Fax: 314-977-6410

Primary Faculty Appointments

NameDegree InstitutionAcademic Interest
Thomas P. Burris, Ph.D.
Ph.D., The Florida State University
Michael Ariel, Ph.D.
Washington University, 1980

Sensorimotor information processing from visual and vestibular inputs that control eye movements.

Joseph Baldassare, Ph.D.
MIT and University of Pittsburgh, 1971

Cell-cycle regulation and intracellular signal transduction mechanisms.

Andrew A. Butler, Ph.D

University of Auckland, Auckland, New Zealand (1995)

Neural “nutrient sensing networks” control ingestive behaviors and metabolism to maintain metabolic homeostasis and a healthy body weight.

John C. Chrivia, Ph.D.
University of Washington, 1987

Transcriptional reegulation by coactivators and nuclear receptors.

Jane Cox, Ph.D.
Ireland (Dublin), 1983

Neurotransmitter receptors; molecular biology and developmental regulation of glutamate and P2X receptors.

Terrance M. Egan, Ph.D.
M.I.T., 1984

Receptor and voltage gated ion channels.

Decha Enkvetchakul, M.D.
University of Missouri, Columbia, 1993

Structural mechanisms underlying modulation of KirBac1.1 channel activity by membrane lipids and protons.

Colin A. Flaveny Ph.D.
Doctor of Philosophy, Molecular Toxicology 08/04-05/10
The Pennsylvania State University, University Park PA
Pharmacological targeting of LXR to treat prostate cancer
Amy Harkins, Ph.D.
Department of Biomedical Engineering,
Saint Louis University (secondary appointment)
University of Pennsylvania, 1993

Cellular and molecular mechanisms of synaptic vesicle release; calcium channels.

Mark M. Knuepfer, Ph.D.
Iowa, 1981

Autonomic pharmacology and physiology; central cardiovascular regulation; electrophysiology; effects of cocaine, stress and endotoxemia.

Andrew Lechner, Ph.D.
University of California, Riverside, 1977

Pulmonary physiology; acute lung injury and the immunophysiology of sepsis.

Heather Macarthur, Ph.D.
William Harvey Research Institute, Saint Bartholomew's Medical College, London, 1994

Vascular control mechanisms; endothelial mediators; sympathetic neurotransmission.

W. Michael Panneton, Ph.D.
The Ohio State University, 1978

The etiology of Parkinson disease; neural pathways mediating deep chronic pain; neural integration of somatautonomic reflexes (the diving response).

Daniela Salvemini, Ph.D.
University of London, 1990

Role of reactive oxygen and nitrogen  species and lipid mediators in acute and chronic pain and in the development of opiate antinociceptive tolerance.

Willis K. Samson, Ph.D., D.Sc.
University of Texas, 1979

Neuropeptides and the control of cardiovascular function and stress hormone secretion

Randy S. Sprague, M.D.
Saint Louis University, 1976

The role of the red blood cell as a determinant of vascular resistance.

Alan H. Stephenson, Ph.D.
Saint Louis University, 1986

Vascular control mechanisms: eicosanoids, pulmonary & cardiovascular science.

Mark M. Voigt, Ph.D.
Saint Louis University, 1985

Biochemical and molecular neuropharmcology and neuroscience; molecular biology and development regulation of purinergic receptors; development of sensory neurons in zeberafish.

John K. Walker, Ph.D.
Ph.D. 1998, Indiana University, Bloomington, IN Medicinal Chemistry and Drug Design

Research Interests: Our laboratory is focused on the application of medicinal and synthetic organic chemistry toward the development of potential new therapeutic agents. We rely on structure based drug design and ligand based drug design techniques as well traditional medicinal chemistry principles to design these new molecules. Our research is highly collaborative and we are engaged in projects with a number of groups looking at new drug targets for anti-inflammatory, anti-bacterial and anti-caner agents.

Thomas C. Westfall, Ph.D.
West Virginia, 1962

William Beaumont Professor, Chair Emeritus
Biochemical neuropharmacology; monoamine and peptide regulation; autonomic pharmacology and cardiovascular science.

Gina Yosten, Ph.D.
Ph.D., Saint Louis University

Role of Orphan GPCRs in Obesity- and Diabetes-Associated Cardiovascular Disease

Daniel S. Zahm, Ph.D.
Pennsylvania State University, 1982

Neuroanatomical and functional organization of basal forebrain; neurodegeneration, role of peptides in psychostimulant and opioid actions.

Jinsong Zhang, Ph.D.

Ph.D., University of Pennsylvania (1999)

Transcriptional regulation in animal cells
© 1818 - 2016  SAINT LOUIS UNIVERSITY   |   Disclaimer